retatrutide phase 2 trial results Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Retatrutide Phase 3: TRIUMPH Program

It not only stimulates collagen production, enhancing skin elasticity and firmness, but also improves skin hydration and protects against oxidative stress

Most people eventually stop taking a GLP-1 estimates reach as high as 92% which means medication alone is not enough

The product also includes BCAAs that support muscle endurance and power, plus contribute to a healthier gut environment

At Doctor Tony Clinic, we recommend starting with a lower dosage and gradually increasing it as your body becomes accustomed to the treatment

As mentioned above, tirzepatide hasnt been compared to the higher dose of semaglutide (Wegovy) now available

For very small doses (under 50mcg), consider adding more BAC water to your vial to create a lower concentration